Literature DB >> 1796043

Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.

K Nishida1, Y Eguchi, T Takino, Y Takakura, M Hashida, H Sezaki.   

Abstract

The hepatic disposition of lactosaminated bovine serum albumin (Lac-BSA) in rats was studied at the whole body, isolated liver, and isolated parenchymal cell levels. After intravenous injection, 111In-Lac-BSA (1 mg/kg) was rapidly eliminated from the plasma due to extensive uptake by liver parenchymal cells; however, a significant decrease in hepatic clearance was observed at high dose (50 mg/kg). In a single-pass, constant infusion experiment in the isolated liver, 111In-Lac-BSA was continuously extracted. The extraction ratio at steady state (Ess) for 111In-Lac-BSA was significantly decreased by coadministrating galactose, NH4Cl, or chloroquine, and at low temperature, suggesting that hepatic uptake of Lac-BSA proceeds via receptor-mediated endocytosis for asialoglycoprotein. Kinetic analysis of 111In-Lac-BSA binding with isolated parenchymal cells at 4 degrees C yielded a dissociation constant (Kd) of 2.5 x 10(-8) M and a value of 3.5 x 10(5) maximal binding sites/cell (Bmax). The internalization rate constant (kint) for 111In-Lac-BSA was calculated to be 0.46 min-1 in liver perfusion experiments using the EDTA-wash method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1796043     DOI: 10.1023/a:1015895511208

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver.

Authors:  K Nishida; K Mihara; T Takino; S Nakane; Y Takakura; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

2.  Endocytosis and degradation mediated by the asialoglycoprotein receptor in isolated rat hepatocytes.

Authors:  P H Weigel; J A Oka
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

Review 3.  Carbohydrate-specific receptors of the liver.

Authors:  G Ashwell; J Harford
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

4.  Uptake and degradation of 125I-labelled asialo-fetuin by isolated rat hepatocytes.

Authors:  H Tolleshaug; T Berg; M Nilsson; K R Norum
Journal:  Biochim Biophys Acta       Date:  1977-08-25

5.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

6.  The preparation and labeling of DTPA-coupled albumin.

Authors:  D J Hnatowich; W W Layne; R L Childs
Journal:  Int J Appl Radiat Isot       Date:  1982-05

7.  Cell surface distribution and intracellular fate of asialoglycoproteins: a morphological and biochemical study of isolated rat hepatocytes and monolayer cultures.

Authors:  P L Zeitlin; A L Hubbard
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

8.  Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver.

Authors:  E R Weibel; W Stäubli; H R Gnägi; F A Hess
Journal:  J Cell Biol       Date:  1969-07       Impact factor: 10.539

9.  Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells.

Authors:  A L Schwartz; A Bolognesi; S E Fridovich
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

10.  An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. I. Distribution of 125I-ligands among the liver cell types.

Authors:  A L Hubbard; G Wilson; G Ashwell; H Stukenbrok
Journal:  J Cell Biol       Date:  1979-10       Impact factor: 10.539

View more
  1 in total

1.  Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.

Authors:  Shintaro Fumoto; Fumi Nakadori; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.